Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ADRB1 Antikörper (Internal Region)

Verified ADRB1 Reaktivität: Human ELISA, IHC, IF Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN185584
  • Target Alle ADRB1 Antikörper anzeigen
    ADRB1 (Adrenergic, beta-1-, Receptor (ADRB1))
    Bindungsspezifität
    • 16
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reaktivität
    • 41
    • 27
    • 26
    • 5
    • 5
    • 2
    • 1
    • 1
    Human
    Wirt
    • 43
    Ziege
    Klonalität
    • 43
    Polyklonal
    Konjugat
    • 13
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ADRB1 Antikörper ist unkonjugiert
    Applikation
    • 31
    • 18
    • 13
    • 13
    • 10
    • 6
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Verwendungszweck
    ADRB1
    Sequenz
    ESDEARRCYN DPK
    Kreuzreaktivität
    Hund, Human, Maus, Ratte
    Aufreinigung
    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
    Güteklasse
    Verified
    Immunogen
    Peptide with sequence ESDEARRCYNDPK, from the internal region of the protein sequence according to NP_000675.1.
    Isotyp
    IgG
  • Applikationshinweise

    Immunohistochemistry: Paraffin embedded Human Heart. Recommended concentration: 6 μg/mL.

    Western Blot: This antibody is not recommended for use in Western blotting.

    Peptide ELISA: antibody detection limit dilution 1:2000.

    Kommentare

    Immunofluorescence: Strong expression of the protein seen in the plama membrane and cytoplasm of HeLa cells. Recommended concentration: 10μg/ml.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Minimize freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
  • Wenzel, Schulze-Rothe, Müller, Wallukat, Haberland: "Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology." in: PLoS ONE, Vol. 13, Issue 2, pp. e0192615, (2018) (PubMed).

    Wallukat, Prüss, Müller, Schimke: "Functional autoantibodies in patients with different forms of dementia." in: PLoS ONE, Vol. 13, Issue 3, pp. e0192778, (2018) (PubMed).

    Wenzel, Schulze-Rothe, Haberland, Müller, Wallukat, Davideit: "Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy." in: Heliyon, Vol. 3, Issue 7, pp. e00362, (2017) (PubMed).

    Wallukat, Haberland, Berg, Schulz, Freyse, Dahmen, Kage, Dandel, Vetter, Salzsieder, Kreutz, Schimke: "The first aptamer-apheresis column specifically for clearing blood of ?1-receptor autoantibodies." in: Circulation journal : official journal of the Japanese Circulation Society, Vol. 76, Issue 10, pp. 2449-55, (2012) (PubMed).

    Haberland, Wallukat, Dahmen, Kage, Schimke: "Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies." in: Circulation research, Vol. 109, Issue 9, pp. 986-92, (2011) (PubMed).

    Wallukat, Muñoz Saravia, Haberland, Bartel, Araujo, Valda, Duchen, Diaz Ramirez, Borges, Schimke: "Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients." in: Journal of the American College of Cardiology, Vol. 55, Issue 5, pp. 463-8, (2010) (PubMed).

  • Target
    ADRB1 (Adrenergic, beta-1-, Receptor (ADRB1))
    Andere Bezeichnung
    ADRB1 (ADRB1 Produkte)
    Synonyme
    ADRB1R antikoerper, B1AR antikoerper, BETA1AR antikoerper, RHR antikoerper, RATB1AR antikoerper, X-Beta1AR antikoerper, BAR1 antikoerper, zgc:194728 antikoerper, zgc:194731 antikoerper, ADRB1 antikoerper, Adrb-1 antikoerper, beta-AR antikoerper, adrenoceptor beta 1 antikoerper, adrenoceptor beta 1 L homeolog antikoerper, adrenergic, beta-1-, receptor antikoerper, adrenergic receptor, beta 1 antikoerper, ADRB1 antikoerper, Adrb1 antikoerper, adrb1.L antikoerper, adrb1 antikoerper
    Hintergrund
    ADRB1, adrenergic, beta-1-, receptor, ADRB1R, B1AR, BETA1AR, RHR, beta-1-adrenergic receptor
    Molekulargewicht
    51.2kDa
    Gen-ID
    153
    NCBI Accession
    NP_000675
    Pathways
    cAMP Metabolic Process, Cellular Glucan Metabolic Process, Regulation of Muscle Cell Differentiation, Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Brown Fat Cell Differentiation
Sie sind hier:
Kundenservice